Employees: 03 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1990-09-17 (35 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13014), Bouches-du-Rhone
SELARL PHARMACIE TOMMASINO : revenue, balance sheet and financial ratios
SELARL PHARMACIE TOMMASINO is a French company
founded 35 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13014),
this company of category PME
shows in 2022 a revenue of 2.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE TOMMASINO (SIREN 380269852)
Indicator
2024
2023
2022
2021
2020
2019
2016
2015
Revenue
N/C
N/C
2 557 158 €
N/C
N/C
N/C
1 508 225 €
1 584 782 €
Net income
59 543 €
42 737 €
112 827 €
178 120 €
68 508 €
43 613 €
25 970 €
57 755 €
EBITDA
N/C
N/C
182 179 €
N/C
N/C
N/C
36 323 €
68 927 €
Net margin
N/C
N/C
4.4%
N/C
N/C
N/C
1.7%
3.6%
Revenue and income statement
In 2024, SELARL PHARMACIE TOMMASINO generates positive net income of 60 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 58 k€ -> 60 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
59 543 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 10%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 81%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
9.583%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
81.19%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2019
2020
2021
2022
2023
2024
Debt ratio
13.311
9.305
4.57
20.627
15.957
12.865
10.984
9.583
Financial autonomy
76.758
77.636
80.485
71.295
71.903
73.119
76.23
81.19
Repayment capacity
2.125
3.124
None
None
None
1.043
None
None
Cash flow / Revenue
3.429%
1.765%
None%
None%
None%
5.555%
None%
None%
Sector positioning
Debt ratio
9.582024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELARL PHARMACIE TOMMASINO (9.58) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
81.19%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+8 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE TOMMASINO (81.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
1.04 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of SELARL PHARMACIE TOMMASINO (1.04) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 258.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2019
2020
2021
2022
2023
2024
Liquidity ratio
151.361
139.177
134.721
149.958
184.887
196.193
204.248
258.005
Interest coverage
3.427
5.333
None
None
None
0.642
None
None
Sector positioning
Liquidity ratio
258.02024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+26 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE TOMMASINO (258.00) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.64x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of SELARL PHARMACIE TOMMASINO (0.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE TOMMASINO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2019
2020
2021
2022
2023
2024
Operating WCR
168 177 €
187 171 €
0 €
0 €
0 €
335 806 €
0 €
0 €
Inventory turnover (days)
35
37
0
0
0
27
0
0
Customer payment term (days)
6
3
0
0
0
9
0
0
Supplier payment term (days)
29
40
0
0
0
39
0
0
Positioning of SELARL PHARMACIE TOMMASINO in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE TOMMASINO is estimated at
831 264 €
(range 578 879€ - 1 243 618€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
578k€831k€1243k€
831 264 €Range: 578 879€ - 1 243 618€
NAF 5 année 2024
Valuation method used
Net Income Multiple
59 543 €
×
14.0x
=831 264 €
Range: 578 879€ - 1 243 619€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE TOMMASINO with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE TOMMASINO
What is the revenue of SELARL PHARMACIE TOMMASINO ?
The revenue of SELARL PHARMACIE TOMMASINO in 2022 is 2.6 M€.
Is SELARL PHARMACIE TOMMASINO profitable?
Yes, SELARL PHARMACIE TOMMASINO generated a net profit of 60 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE TOMMASINO ?
The headquarters of SELARL PHARMACIE TOMMASINO is located in MARSEILLE (13014), in the department Bouches-du-Rhone.
Where to find the tax return of SELARL PHARMACIE TOMMASINO ?
The tax return of SELARL PHARMACIE TOMMASINO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE TOMMASINO operate?
SELARL PHARMACIE TOMMASINO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart